Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

Nuvation Bio named Philippe Sauvage as its chief financial officer, filling the position more than 10 months after the prior CFO left.

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

Kymera Therapeutics is a biotech company with innovative technology targeting disease-causing proteins, offering promising ...

Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In ...

Investment banks, forced to take big writedowns on risky merger and acquisitions loans after a global surge in interest rates, are now jumping back into leveraged buyouts — one of the most lucrative ...

On Friday, Italian pharma company Recordati S.p.A agreed to acquire the global rights to Enjaymo (sutimlimab) from Sanofi SA (NASDAQ:SNY) for $825 million as an upfront payment and additional ...

The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising ...

Attorney General Bridget Hill announced a settlement with Sanofi-Aventis U.S. LLC (Sanofi), which guarantees that Wyoming residents not enrolled in government health care programs can buy Sanofi’s ins ...

One of the biggest contract drug manufacturing plants in the US owned by Thermo Fisher Scientific (NYSE: TMO) has repeatedly broken rules designed to ensure that ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...